Role of peptide leukotrienes in monocrotaline-induced lung disease

S. Ono, M. Noda, T. Tanita, Yasushi Hoshikawa, T. Tabata, S. Ueda, T. Nishimura, Y. Ashino, K. Koike, S. Fujimura

Research output: Contribution to journalArticle

Abstract

Monocrotaline (MCT) causes lung inflammation and right ventricular hypertrophy associated with lung vascular thickening in rats. We hypothesized that peptide leukotrienes play a role in MCT-induced lung disease, and examined the effect of ONO 1078, a specific antagonist of LTC4, D4 and E4 receptors on MCT-induced right ventricular hypertrophy and on lung vascular thickening. Next, we measured leukotriene C4 (LTC4) levels in the lung tissue of MCT-treated rats. Within 3 weeks after the injection MCT had caused an increase in the ratio of right ventricular weight to left ventricle + septum weight (RV/(LV + S)) and an increase in media wall thickness of the muscular arteries of the lung. In rats given both ONO 1078 and MCT, these changes were significantly less severe than in rats given MCT only. The LTC4 levels in MCT-treated rats were significantly higher than in saline-treated control rats. These results indicate that this antagonist of peptide leukotriene receptors inhibits right ventricular hypertrophy induced by MCT, and suggest a role for peptide leukotrienes in the inflammatory process that contributes to lung vascular remodeling in MCT-treated rats.

Original languageEnglish
Pages (from-to)1415-1420
Number of pages6
JournalJapanese Journal of Thoracic Diseases
Volume33
Issue number12
Publication statusPublished - 01-12-1995

Fingerprint

Monocrotaline
Leukotrienes
Lung Diseases
Peptides
Right Ventricular Hypertrophy
Lung
Leukotriene C4
Blood Vessels
Leukotriene Antagonists
Weights and Measures
Peptide Receptors
Heart Ventricles
Pneumonia
Arteries

All Science Journal Classification (ASJC) codes

  • Pulmonary and Respiratory Medicine

Cite this

Ono, S., Noda, M., Tanita, T., Hoshikawa, Y., Tabata, T., Ueda, S., ... Fujimura, S. (1995). Role of peptide leukotrienes in monocrotaline-induced lung disease. Japanese Journal of Thoracic Diseases, 33(12), 1415-1420.
Ono, S. ; Noda, M. ; Tanita, T. ; Hoshikawa, Yasushi ; Tabata, T. ; Ueda, S. ; Nishimura, T. ; Ashino, Y. ; Koike, K. ; Fujimura, S. / Role of peptide leukotrienes in monocrotaline-induced lung disease. In: Japanese Journal of Thoracic Diseases. 1995 ; Vol. 33, No. 12. pp. 1415-1420.
@article{20fd9bc89b464a9792fca8500dc775b8,
title = "Role of peptide leukotrienes in monocrotaline-induced lung disease",
abstract = "Monocrotaline (MCT) causes lung inflammation and right ventricular hypertrophy associated with lung vascular thickening in rats. We hypothesized that peptide leukotrienes play a role in MCT-induced lung disease, and examined the effect of ONO 1078, a specific antagonist of LTC4, D4 and E4 receptors on MCT-induced right ventricular hypertrophy and on lung vascular thickening. Next, we measured leukotriene C4 (LTC4) levels in the lung tissue of MCT-treated rats. Within 3 weeks after the injection MCT had caused an increase in the ratio of right ventricular weight to left ventricle + septum weight (RV/(LV + S)) and an increase in media wall thickness of the muscular arteries of the lung. In rats given both ONO 1078 and MCT, these changes were significantly less severe than in rats given MCT only. The LTC4 levels in MCT-treated rats were significantly higher than in saline-treated control rats. These results indicate that this antagonist of peptide leukotriene receptors inhibits right ventricular hypertrophy induced by MCT, and suggest a role for peptide leukotrienes in the inflammatory process that contributes to lung vascular remodeling in MCT-treated rats.",
author = "S. Ono and M. Noda and T. Tanita and Yasushi Hoshikawa and T. Tabata and S. Ueda and T. Nishimura and Y. Ashino and K. Koike and S. Fujimura",
year = "1995",
month = "12",
day = "1",
language = "English",
volume = "33",
pages = "1415--1420",
journal = "Respiratory Investigation",
issn = "2212-5345",
publisher = "Elsevier BV",
number = "12",

}

Ono, S, Noda, M, Tanita, T, Hoshikawa, Y, Tabata, T, Ueda, S, Nishimura, T, Ashino, Y, Koike, K & Fujimura, S 1995, 'Role of peptide leukotrienes in monocrotaline-induced lung disease', Japanese Journal of Thoracic Diseases, vol. 33, no. 12, pp. 1415-1420.

Role of peptide leukotrienes in monocrotaline-induced lung disease. / Ono, S.; Noda, M.; Tanita, T.; Hoshikawa, Yasushi; Tabata, T.; Ueda, S.; Nishimura, T.; Ashino, Y.; Koike, K.; Fujimura, S.

In: Japanese Journal of Thoracic Diseases, Vol. 33, No. 12, 01.12.1995, p. 1415-1420.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Role of peptide leukotrienes in monocrotaline-induced lung disease

AU - Ono, S.

AU - Noda, M.

AU - Tanita, T.

AU - Hoshikawa, Yasushi

AU - Tabata, T.

AU - Ueda, S.

AU - Nishimura, T.

AU - Ashino, Y.

AU - Koike, K.

AU - Fujimura, S.

PY - 1995/12/1

Y1 - 1995/12/1

N2 - Monocrotaline (MCT) causes lung inflammation and right ventricular hypertrophy associated with lung vascular thickening in rats. We hypothesized that peptide leukotrienes play a role in MCT-induced lung disease, and examined the effect of ONO 1078, a specific antagonist of LTC4, D4 and E4 receptors on MCT-induced right ventricular hypertrophy and on lung vascular thickening. Next, we measured leukotriene C4 (LTC4) levels in the lung tissue of MCT-treated rats. Within 3 weeks after the injection MCT had caused an increase in the ratio of right ventricular weight to left ventricle + septum weight (RV/(LV + S)) and an increase in media wall thickness of the muscular arteries of the lung. In rats given both ONO 1078 and MCT, these changes were significantly less severe than in rats given MCT only. The LTC4 levels in MCT-treated rats were significantly higher than in saline-treated control rats. These results indicate that this antagonist of peptide leukotriene receptors inhibits right ventricular hypertrophy induced by MCT, and suggest a role for peptide leukotrienes in the inflammatory process that contributes to lung vascular remodeling in MCT-treated rats.

AB - Monocrotaline (MCT) causes lung inflammation and right ventricular hypertrophy associated with lung vascular thickening in rats. We hypothesized that peptide leukotrienes play a role in MCT-induced lung disease, and examined the effect of ONO 1078, a specific antagonist of LTC4, D4 and E4 receptors on MCT-induced right ventricular hypertrophy and on lung vascular thickening. Next, we measured leukotriene C4 (LTC4) levels in the lung tissue of MCT-treated rats. Within 3 weeks after the injection MCT had caused an increase in the ratio of right ventricular weight to left ventricle + septum weight (RV/(LV + S)) and an increase in media wall thickness of the muscular arteries of the lung. In rats given both ONO 1078 and MCT, these changes were significantly less severe than in rats given MCT only. The LTC4 levels in MCT-treated rats were significantly higher than in saline-treated control rats. These results indicate that this antagonist of peptide leukotriene receptors inhibits right ventricular hypertrophy induced by MCT, and suggest a role for peptide leukotrienes in the inflammatory process that contributes to lung vascular remodeling in MCT-treated rats.

UR - http://www.scopus.com/inward/record.url?scp=0029619372&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029619372&partnerID=8YFLogxK

M3 - Article

C2 - 8821996

AN - SCOPUS:0029619372

VL - 33

SP - 1415

EP - 1420

JO - Respiratory Investigation

JF - Respiratory Investigation

SN - 2212-5345

IS - 12

ER -

Ono S, Noda M, Tanita T, Hoshikawa Y, Tabata T, Ueda S et al. Role of peptide leukotrienes in monocrotaline-induced lung disease. Japanese Journal of Thoracic Diseases. 1995 Dec 1;33(12):1415-1420.